These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 7189001

  • 1. Optic neuritis and chronic relapsing experimental allergic encephalomyelitis: relationship to clinical course and comparison with multiple sclerosis.
    Raine CS, Traugott U, Nussenblatt RB, Stone SH.
    Lab Invest; 1980 Mar; 42(3):327-35. PubMed ID: 7189001
    [Abstract] [Full Text] [Related]

  • 2. Induction of oligodendrocyte proliferation and remyelination after chronic demyelination. Relevance to multiple sclerosis.
    Raine CS, Moore GR, Hintzen R, Traugott U.
    Lab Invest; 1988 Oct; 59(4):467-76. PubMed ID: 2459499
    [Abstract] [Full Text] [Related]

  • 3. Adoptively transferred chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Neuropathologic analysis.
    Raine CS, Mokhtarian F, McFarlin DE.
    Lab Invest; 1984 Nov; 51(5):534-46. PubMed ID: 6208409
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term suppression of neurodegeneration in chronic experimental optic neuritis: antioxidant gene therapy.
    Qi X, Sun L, Lewin AS, Hauswirth WW, Guy J.
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5360-70. PubMed ID: 18055782
    [Abstract] [Full Text] [Related]

  • 6. Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse.
    Brown A, McFarlin DE, Raine CS.
    Lab Invest; 1982 Feb; 46(2):171-85. PubMed ID: 7062721
    [Abstract] [Full Text] [Related]

  • 7. Chronic experimental allergic optic neuritis.
    Rao NA.
    Invest Ophthalmol Vis Sci; 1981 Feb; 20(2):159-72. PubMed ID: 6161902
    [No Abstract] [Full Text] [Related]

  • 8. Axonal dystrophy as a consequence of long-term demyelination.
    Raine CS, Cross AH.
    Lab Invest; 1989 May; 60(5):714-25. PubMed ID: 2716284
    [Abstract] [Full Text] [Related]

  • 9. Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis.
    Qi X, Lewin AS, Sun L, Hauswirth WW, Guy J.
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):681-91. PubMed ID: 17251466
    [Abstract] [Full Text] [Related]

  • 10. Morphological changes in the skin during experimental allergic encephalomyelitis and multiple sclerosis: bases for new diagnostic test.
    Bisaga GN, Onishchenko LS, Adel'son LN.
    Bull Exp Biol Med; 2000 Oct; 130(10):1005-10. PubMed ID: 11177306
    [Abstract] [Full Text] [Related]

  • 11. [Experimental allergic encephalomyelitis as an animal model for multiple sclerosis].
    Lukinović-Skudar V, Taradi SK, Andreis I, Zupancić V, Taradi M.
    Lijec Vjesn; 2001 Oct; 123(3-4):81-8. PubMed ID: 11488222
    [Abstract] [Full Text] [Related]

  • 12. A morphologic comparison of three experimental models of experimental allergic encephalomyelitis with multiple sclerosis.
    Shaw CM, Alvord EC.
    Prog Clin Biol Res; 1984 Oct; 146():61-6. PubMed ID: 6201924
    [No Abstract] [Full Text] [Related]

  • 13. Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis.
    Massacesi L, Genain CP, Lee-Parritz D, Letvin NL, Canfield D, Hauser SL.
    Ann Neurol; 1995 Apr; 37(4):519-30. PubMed ID: 7717689
    [Abstract] [Full Text] [Related]

  • 14. Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis.
    Wiśniewski HM, Keith AB.
    Ann Neurol; 1977 Feb; 1(2):144-8. PubMed ID: 889297
    [No Abstract] [Full Text] [Related]

  • 15. An ultrastructural study of experimental demyelination and remyelination. 3. Chronic experimental allergic encephalomyelitis in the central nervous system.
    Prineas J, Raine CS, Wísniewski H.
    Lab Invest; 1969 Dec; 21(6):472-83. PubMed ID: 5356782
    [No Abstract] [Full Text] [Related]

  • 16. [Pathology and pathogenesis of multiple sclerosis from the viewpoint of neurologic disease research].
    Seitelberger F.
    Wien Med Wochenschr; 1985 Jan 31; 135(1-2):6-7. PubMed ID: 3976241
    [Abstract] [Full Text] [Related]

  • 17. Disruption of the blood-brain barrier in experimental optic neuritis: immunocytochemical co-localization of H2O2 and extravasated serum albumin.
    Guy J, McGorray S, Fitzsimmons J, Beck B, Rao NA.
    Invest Ophthalmol Vis Sci; 1994 Mar 31; 35(3):1114-23. PubMed ID: 8125722
    [Abstract] [Full Text] [Related]

  • 18. Experimental allergic encephalomyelitis, experimental allergic neuritis and multiple sclerosis: an electromyographic study.
    McPherson TA, Kiss ZS, Robson G, Kirsner LG, Dewhurst DJ.
    Proc Aust Assoc Neurol; 1969 Mar 31; 6():149-53. PubMed ID: 5349187
    [No Abstract] [Full Text] [Related]

  • 19. Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis.
    Diem R, Sättler MB, Merkler D, Demmer I, Maier K, Stadelmann C, Ehrenreich H, Bähr M.
    Brain; 2005 Feb 31; 128(Pt 2):375-85. PubMed ID: 15601662
    [Abstract] [Full Text] [Related]

  • 20. Optic nerve diffusion changes and atrophy jointly predict visual dysfunction after optic neuritis.
    Kolbe S, Chapman C, Nguyen T, Bajraszewski C, Johnston L, Kean M, Mitchell P, Paine M, Butzkueven H, Kilpatrick T, Egan G.
    Neuroimage; 2009 Apr 15; 45(3):679-86. PubMed ID: 19162205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.